Reduced liver damage and fibrosis with combined SCD Probiotics and intermittent fasting in aged rat

dc.contributor.authorTeker, Hikmet Taner
dc.contributor.authorCeylani, Taha
dc.contributor.authorKeskin, Seda
dc.contributor.authorSamgane, Gizem
dc.contributor.authorBaba, Burcu
dc.contributor.authorAcikgoz, Eda
dc.contributor.authorGurbanov, Rafig
dc.date.accessioned2024-12-14T22:07:24Z
dc.date.available2024-12-14T22:07:24Z
dc.date.issued2024
dc.departmentMuş Alparslan Üniversitesien_US
dc.description.abstractThis study aimed to examine the impact of SCD Probiotics supplementation on liver biomolecule content and histological changes during a 30-day intermittent fasting (IF) program in 24-month-old male Sprague-Dawley rats. Rats underwent 18-h daily fasting and received 1 x 10(8) CFU of SCD Probiotics daily. Liver tissue biomolecules were analysed using FTIR Spectroscopy, LDA, and SVM techniques, while histopathological evaluations used Haematoxylin and eosin and Masson trichrome-stained tissues. Blood samples were collected for biochemical analysis. Gross alterations in the quantity of biomolecules were observed with individual or combined treatments. LDA and SVM analyses demonstrated a high accuracy in differentiating control and treated groups. The combination treatments led to the most significant reduction in cholesterol ester (1740 cm(-1)) and improved protein phosphorylation (A(1239)/A(2955) and A(1080)/A(1545)) and carbonylation (A(1740)/A(1545)). Individually, IF and SCD Probiotics were more effective in enhancing membrane dynamics (Bw(2922)/Bw(2955)). In treated groups, histological evaluations showed decreased hepatocyte degeneration, lymphocyticinfiltration, steatosis and fibrosis. Serum ALP, LDH and albumin levels significantly increased in the SCD Probiotics and combined treatment groups. This study offers valuable insights into the potential mechanisms behind the beneficial effects of IF and SCD Probiotics on liver biomolecule content, contributing to the development of personalized nutrition and health strategies.en_US
dc.identifier.doi10.1111/jcmm.18014
dc.identifier.issn1582-1838
dc.identifier.issn1582-4934
dc.identifier.issue1en_US
dc.identifier.orcid0000-0002-4726-982X
dc.identifier.orcidCeylani, Taha
dc.identifier.orcid0000-0002-3041-6010
dc.identifier.orcid0000-0003-0994-3577
dc.identifier.pmid37897241
dc.identifier.scopus2-s2.0-85175354383
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1111/jcmm.18014
dc.identifier.urihttps://hdl.handle.net/20.500.12639/6589
dc.identifier.volume28en_US
dc.identifier.wosWOS:001092103800001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWileyen_US
dc.relation.ispartofJournal of Cellular and Molecular Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmzKA_20241214
dc.subjectfibrosisen_US
dc.subjectFTIRen_US
dc.subjectintermittent fastingen_US
dc.subjectliveren_US
dc.subjectraten_US
dc.subjectSCD probioticsen_US
dc.titleReduced liver damage and fibrosis with combined SCD Probiotics and intermittent fasting in aged raten_US
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
6589.pdf
Boyut:
17.93 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text